2nd Edition of International Conference on Advanced Pulmonology, Respiratory Medicine & Lung Health
June 28-30, 2027 | Rome, Italy
Pleural Diseases
Emerging imaging tools and procedural techniques have refined the diagnosis and treatment of pleural diseases, including pleural effusion, empyema, pneumothorax, and malignant mesothelioma. Ultrasound-guided thoracentesis, pleural manometry, and indwelling pleural catheters are transforming patient care by reducing complications and enabling ambulatory management. Thoracoscopy remains a cornerstone for diagnosing unexplained effusions and administering talc pleurodesis. Pleural diseases research now focuses on molecular profiling of pleural fluid and minimally invasive biomarkers to improve diagnostic yield. Multidisciplinary input from pulmonologists, thoracic surgeons, and radiologists ensures accurate assessment and tailored treatment plans. Enhanced guidelines and procedural training are improving safety and outcomes across both inpatient and outpatient care environments.
Saurabh Chattopadhyay
University of Kentucky, United States
Yazdan Mirzanejad
University of British Columbia, Canada
Constantinos Mikelis
University of Patras, Greece
Sai Lakkimsetti
Lakeside High School, United States
Mariano Votta
Active Citizenship Network (Cittadinanzattiva), Italy
Vijayan Gurumurthy Iyer
Techno-Economic-Environmental Study and Check Consultancy Services, India
K R Aneja
Kurukshetra University, IndiaSubmit your abstract Today
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation